Advertisement

Topics

FDA Approves Apalutamide for Nonmetastatic Prostate Cancer

11:56 EST 14 Feb 2018 | Medscape

This is the first approved therapy for prostate cancer patients who have nonmetastatic, castration-resistant prostate cancer.
FDA Approvals

Original Article: FDA Approves Apalutamide for Nonmetastatic Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Apalutamide for Nonmetastatic Prostate Cancer"

Advertisement

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
Advertisement

 

Relevant Topic

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio.
All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd.